Snapping up most of Situational Awareness’s public equities portfolio proved a near-immediate coup for Citadel, whose flagship fund rose 5.9%.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Deal or no deal, mere talks between Astrazeneca and Bristol-Myers point to one of the global pharma industry’s biggest themes.
The deal gives Eli Lilly access to a psychedelic-based nasal spray that studies show curbs treatment-resistant depression in a single dose.
The US men’s national soccer team’s World Cup performance is likely to have significant impact on broadcasters and high-flying investors.
Merck KGaA’s agreement to buy Bio-Techne for $11.3 billion strengthens its hold in life sciences, especially drug discovery and gene therapy.
Analysts at Jefferies wrote Thursday that the closure of the Tillman deal could “act as a catalyst” for more M&A in the gambling sector.
Bolloré Group, which holds 40% voting rights in Universal Music, has given a thumbs-down to a $65 billion takeover bid.
GameStop CEO Ryan Cohen is sidestepping questions about how much a proposed takeover of eBay — for $56 billion — would benefit stockholders.
American Airlines, United, Delta and Southwest represent a whopping 75% share of the US aviation market, according to aviation data firm OAG.
The key patent protections on Keytruda, Merck’s immunotherapy treatment that outsold all other prescription drugs last year, ends in 2028.
If, at first, Discovery, AT&T, AOL, Time and others fail? Well, David Ellison is going to go ahead and give Warner Brothers a try anyway.
Netflix, with its 325 million subscribers, swears its potential (if not likely) acquisition of Warner Bros amounts to vertical integration.
JPMorgan and Goldman Sachs proved they’re still the go-to middlemen for Wall Street deals amid a near-record $4.8 trillion global M&A bonanza
Standout deals included Union Pacific’s $88 billion purchase of Norfolk Southern and the $56.6 billion deal to take Electronic Arts private.
That puts the ball back in WBD’s court to reject Paramount’s offer for the eighth time if it chooses to stick with Netflix.
A potential tie-up would come at an interesting crossroads for the theatrical industry and its longtime nemesis, Netflix.